European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Chimeric monoclonal antibody against GD2
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
Chimeric monoclonal antibody against GD2
| EU orphan designation number: | EU/3/11/879
|
| Active ingredient: | Chimeric monoclonal antibody against GD2 |
| Indication: | Treatment of neuroblastoma |
| Sponsor: | United Therapeutics Europe Ltd
Unither House, Curfew Bell Road, Chertsey, Surrey KT16 9FG, United Kingdom |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 24/06/2011 | Centralised Orphan - Designation | EMA/OD/002/11 | (2011)4553 of 21/06/2011 |